0 NASDAQ Companies - October 9, 2024Hydrofarm Holdings Group, Inc. Announces Fireside Chat with Water Tower ResearchSHOEMAKERSVILLE, Pa., Oct. 09, 2024 (GLOBE NEWSWIRE) — Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading […]Read More
0 NASDAQ Companies - October 9, 2024SEALSQ Getting Ready for the Arrival of Quantum Computers as Post-Quantum Cryptographic Algorithms and Semiconductors are the Front-Line of defense Against Adversarial Quantum AttacksGeneva, Switzerland, Oct. 09, 2024 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on […]Read More
0 NASDAQ Companies - October 9, 2024StepStone Private Wealth Surpasses $5 Billion in AUM MilestoneNEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) — StepStone Private Wealth (“SPW”) today announced it has surpassed $5 billion in […]Read More
0 NASDAQ Companies - October 9, 2024VCI Global Unleashes Enterprise AI Solutions with V-Gallant, Leveraging NVIDIA’s Computing InfrastructureKUALA LUMPUR, Malaysia, Oct. 09, 2024 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (Frankfurt: H0T) (“VCI Global” or the […]Read More
0 NASDAQ Companies - October 9, 2024Inhibikase Therapeutics Announces Pricing of $110 Million Private Placement to Advance IkT-001Pro, an Optimized Prodrug of Imatinib, into a Late-Stage Trial in Pulmonary Arterial Hypertension— Aggregate investment of up to approximately $275 Million by healthcare-focused investment funds, led by Soleus Capital — BOSTON and […]Read More
0 NASDAQ Companies - October 9, 2024La Rosa Holdings Launches My Agent Account Version 3.0 with Enhanced Property Management Disbursement Features; Expected to Enhance La Rosa’s Agents’ Productivity and Efficiency by 50% by Year-EndCelebration, FL, Oct. 09, 2024 (GLOBE NEWSWIRE) — La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a holding […]Read More
0 NASDAQ Companies - October 9, 2024Capricor Therapeutics Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy-Company Plans to Complete Rolling BLA Submission by End of 2024; Application May be Eligible for Priority Review by FDA- […]Read More
0 NASDAQ Companies - October 9, 2024Cyclacel Pharmaceuticals to Present New Clinical Data From Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR SymposiumBERKELEY HEIGHTS, N.J., Oct. 09, 2024 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), […]Read More
0 NASDAQ Companies - October 9, 2024Mather Al-Ali Joins Vislink as Vice President of Sales for Middle East and Africa RegionMt. Olive, New Jersey, Oct. 09, 2024 (GLOBE NEWSWIRE) — Vislink Technologies, Inc. (NASDAQ: VISL), a global leader in live […]Read More
0 NASDAQ Companies - October 9, 2024Avalon GloboCare to Sponsor Keto Pa-LOU-za 2024 Conference and Showcase KetoAir Breathalyzer DeviceFREEHOLD, N.J., Oct. 09, 2024 (GLOBE NEWSWIRE) — Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of […]Read More